Aion Therapeutic Inc (TSE:AION) has released an update.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Aion Therapeutic Inc. has issued a bi-weekly update on its management cease trade order, stating it is still in the process of completing its annual and interim financial statements due to complications from a recent acquisition. The company has been granted an extension until October 28, 2024, by the British Columbia Securities Commission and confirms no other material changes or insolvency proceedings are affecting its status.
For further insights into TSE:AION stock, check out TipRanks’ Stock Analysis page.